Elaine V Jones - Net Worth and Insider Trading

Elaine V Jones Net Worth

The estimated net worth of Elaine V Jones is at least $9,718 dollars as of 2024-05-20. Elaine V Jones is the Director of CytomX Therapeutics Inc and owns about 5,142 shares of CytomX Therapeutics Inc (CTMX) stock worth over $9,718. Details can be seen in Elaine V Jones's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Elaine V Jones has not made any transactions after 2023-03-29 and currently still holds the listed stock(s).

Transaction Summary of Elaine V Jones

Elaine V Jones Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Elaine V Jones owns 10 companies in total, including Gritstone Bio Inc (GRTS) , CytomX Therapeutics Inc (CTMX) , and NextCure Inc (NXTC) among others .

Click here to see the complete history of Elaine V Jones’s form 4 insider trades.

Insider Ownership Summary of Elaine V Jones

Ticker	Comapny	Transaction Date	Type of Owner
GRTS	Gritstone Bio Inc	2023-06-16	director
CTMX	CytomX Therapeutics Inc	2023-03-29	director
NXTC	NextCure Inc	2019-05-08	director
		2017-06-27	director
		2015-09-30	director
		2014-03-06	director
		2014-02-11	director
		2006-04-11	director
		2021-02-25	director
		2021-02-25	director

Elaine V Jones Latest Holdings Summary

Elaine V Jones currently owns a total of 1 stock. Elaine V Jones owns 5,142 shares of CytomX Therapeutics Inc (CTMX) as of March 29, 2023, with a value of $9,718.

Latest Holdings of Elaine V Jones

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
CTMX	CytomX Therapeutics Inc	2023-03-29	5,142	1.89	9,718

Holding Weightings of Elaine V Jones

Elaine V Jones Form 4 Trading Tracker

According to the SEC Form 4 filings, Elaine V Jones has made a total of 1 transactions in CytomX Therapeutics Inc (CTMX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in CytomX Therapeutics Inc is the acquisition of 5,000 shares on March 29, 2023, which cost Elaine V Jones around $7,750.

Insider Trading History of Elaine V Jones

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Elaine V Jones Trading Performance

GuruFocus tracks the stock performance after each of Elaine V Jones's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Elaine V Jones is -8.14%. GuruFocus also compares Elaine V Jones's trading performance to market benchmark return within the same time period. The performance of stocks bought by Elaine V Jones within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Elaine V Jones's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Elaine V Jones

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	6.19
Relative Return to S&P 500(%)	2.67

Elaine V Jones Ownership Network

Ownership Network List of Elaine V Jones

No Data

Ownership Network Relation of Elaine V Jones

Elaine V Jones Owned Company Details

What does Gritstone Bio Inc do?

Who are the key executives at Gritstone Bio Inc?

Elaine V Jones is the director of Gritstone Bio Inc. Other key executives at Gritstone Bio Inc include director & President and CEO Andrew R Allen , See Remarks Matthew Hawryluk , and See Remarks Karin Jooss .

Gritstone Bio Inc (GRTS) Insider Trades Summary

Over the past 18 months, Elaine V Jones made no insider transaction in Gritstone Bio Inc (GRTS). Other recent insider transactions involving Gritstone Bio Inc (GRTS) include a net sale of 1,749 shares made by Vassiliki Economides , a net sale of 24,263 shares made by Andrew R Allen , and a net sale of 13,749 shares made by Karin Jooss .

In summary, during the past 3 months, insiders sold 74,769 shares of Gritstone Bio Inc (GRTS) in total and bought 0 shares, with a net sale of 74,769 shares. During the past 18 months, 74,769 shares of Gritstone Bio Inc (GRTS) were sold and 12,000 shares were bought by its insiders, resulting in a net sale of 62,769 shares.

Gritstone Bio Inc (GRTS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Gritstone Bio Inc Insider Transactions

No Available Data

What does CytomX Therapeutics Inc do?

Who are the key executives at CytomX Therapeutics Inc?

Elaine V Jones is the director of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Chief Scientific Officer Marcia Belvin , SVP & Finance and Accounting Christopher Ogden , and Chief Financial Officer Jeffrey B Landau .

CytomX Therapeutics Inc (CTMX) Insider Trades Summary

Over the past 18 months, Elaine V Jones made 1 insider transaction in CytomX Therapeutics Inc (CTMX) with a net purchase of 5,000. Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 55,496 shares made by Sean A. Mccarthy , a net sale of 16,868 shares made by Lloyd A Rowland , and a net sale of 16,235 shares made by Jeffrey B Landau .

In summary, during the past 3 months, insiders sold 47,819 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 47,819 shares. During the past 18 months, 121,072 shares of CytomX Therapeutics Inc (CTMX) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 116,072 shares.

CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.

CytomX Therapeutics Inc Insider Transactions

No Available Data

What does NextCure Inc do?

Who are the key executives at NextCure Inc?

Elaine V Jones is the director of NextCure Inc. Other key executives at NextCure Inc include Sr VP & Legal Affairs Kevin G. Shaw , Sr VP & Dev. & Mfg. Sourav Kundu , and Chief Medical Officer Han Myint .

NextCure Inc (NXTC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of NextCure Inc (NXTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NextCure Inc (NXTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NextCure Inc (NXTC)'s detailed insider trading history can be found in Insider Trading Tracker table.

NextCure Inc Insider Transactions

No Available Data

What does Mersana Therapeutics Inc do?

Who are the key executives at Mersana Therapeutics Inc?

Elaine V Jones is the director of Mersana Therapeutics Inc. Other key executives at Mersana Therapeutics Inc include Chief Legal Officer Alejandra Carvajal , SVP & Chief Development Officer Mohan Bala , and Chief Manufacturing Officer Tushar Misra .

Mersana Therapeutics Inc (MRSN) Insider Trades Summary

Over the past 18 months, Elaine V Jones made no insider transaction in Mersana Therapeutics Inc (MRSN). Other recent insider transactions involving Mersana Therapeutics Inc (MRSN) include a net sale of 9,107 shares made by Alejandra Carvajal , a net sale of 5,723 shares made by Tushar Misra , and a net sale of 46,745 shares made by Anna Protopapas .

In summary, during the past 3 months, insiders sold 0 shares of Mersana Therapeutics Inc (MRSN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 114,354 shares of Mersana Therapeutics Inc (MRSN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 114,354 shares.

Mersana Therapeutics Inc (MRSN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Mersana Therapeutics Inc Insider Transactions

No Available Data

What does Synlogic Inc do?

Who are the key executives at Synlogic Inc?

Elaine V Jones is the director of Synlogic Inc. Other key executives at Synlogic Inc include Chief Operating Officer Antoine Awad , Chief Financial Officer Michael Vangsted Jensen , and Chief Medical Officer Aoife Brennan .

Synlogic Inc (SYBX) Insider Trades Summary

Over the past 18 months, Elaine V Jones made no insider transaction in Synlogic Inc (SYBX). Other recent insider transactions involving Synlogic Inc (SYBX) include a net sale of 6,810 shares made by Antoine Awad , a net sale of 19,042 shares made by Aoife Brennan , and a net sale of 2,553 shares made by Michael Vangsted Jensen .

In summary, during the past 3 months, insiders sold 560 shares of Synlogic Inc (SYBX) in total and bought 0 shares, with a net sale of 560 shares. During the past 18 months, 28,593 shares of Synlogic Inc (SYBX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 28,593 shares.

Synlogic Inc (SYBX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Synlogic Inc Insider Transactions

No Available Data

What does Neoleukin Therapeutics Inc do?

Who are the key executives at Neoleukin Therapeutics Inc?

Elaine V Jones is the director of Neoleukin Therapeutics Inc. Other key executives at Neoleukin Therapeutics Inc include 10 percent owner Baker Bros. Advisors Lp , Principal Accounting Officer Sean Michael Smith , and Chief Medical Officer Priti Patel .

Neoleukin Therapeutics Inc (NLTX) Insider Trades Summary

Over the past 18 months, Elaine V Jones made no insider transaction in Neoleukin Therapeutics Inc (NLTX). Other recent insider transactions involving Neoleukin Therapeutics Inc (NLTX) include a net sale of 18,149 shares made by Priti Patel , a net sale of 4,639 shares made by Sean Michael Smith , and a net purchase of 2,285,342 shares made by Baker Bros. Advisors Lp .

In summary, during the past 3 months, insiders sold 0 shares of Neoleukin Therapeutics Inc (NLTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,139 shares of Neoleukin Therapeutics Inc (NLTX) were sold and 114,267 shares were bought by its insiders, resulting in a net purchase of 113,128 shares.

Neoleukin Therapeutics Inc (NLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Neoleukin Therapeutics Inc Insider Transactions

No Available Data

What does Flexion Therapeutics Inc do?

Who are the key executives at Flexion Therapeutics Inc?

Elaine V Jones is the director of Flexion Therapeutics Inc. Other key executives at Flexion Therapeutics Inc include Chief Regulatory Officer Kerry Wentworth , General Counsel Mark S. Levine , and Chief Strategy Officer Christina Willwerth .

Flexion Therapeutics Inc (FLXN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Flexion Therapeutics Inc (FLXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Flexion Therapeutics Inc (FLXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Flexion Therapeutics Inc (FLXN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Flexion Therapeutics Inc Insider Transactions

No Available Data

What does Catalyst Biosciences Inc do?

Who are the key executives at Catalyst Biosciences Inc?

Elaine V Jones is the director of Catalyst Biosciences Inc. Other key executives at Catalyst Biosciences Inc include director & Chief Executive Officer Charles C Wu , director & President Songjiang Ma , and Chief Operating Officer Weiguo Ye .

Catalyst Biosciences Inc (CBIO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Catalyst Biosciences Inc (CBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Catalyst Biosciences Inc (CBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Catalyst Biosciences Inc (CBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Catalyst Biosciences Inc Insider Transactions

No Available Data

What does Ibere Pharmaceuticals do?

Who are the key executives at Ibere Pharmaceuticals?

Elaine V Jones is the director of Ibere Pharmaceuticals. Other key executives at Ibere Pharmaceuticals include director & 10 percent owner & Chief Executive Officer Osagie O Imasogie , director & 10 percent owner & Chief Operating Officer Zoltan Kerekes , and director & 10 percent owner & Chief Financial Officer Lisa M. Gray .

Ibere Pharmaceuticals (IBER.U) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ibere Pharmaceuticals (IBER.U) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ibere Pharmaceuticals (IBER.U) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ibere Pharmaceuticals (IBER.U)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ibere Pharmaceuticals Insider Transactions

No Available Data

What does Ibere Pharmaceuticals do?

Who are the key executives at Ibere Pharmaceuticals?

Ibere Pharmaceuticals (IBER) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ibere Pharmaceuticals (IBER) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ibere Pharmaceuticals (IBER) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ibere Pharmaceuticals (IBER)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ibere Pharmaceuticals Insider Transactions

No Available Data

Elaine V Jones Mailing Address

Above is the net worth, insider trading, and ownership report for Elaine V Jones. You might contact Elaine V Jones via mailing address: C/o Targacept, Inc., 200 East First Street, Suite 300, Winston-salem Nc 27101.

Discussions on Elaine V Jones

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.